Fig. 4From: A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluationPhase II Cyberknife plan for Patient B treated after revision of dose constraints. Phase II distribution (top) and radiotherapy target/organ at risk doses (bottom) are displayedBack to article page